Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |